India is witnessing a significant rise in respiratory diseases such as asthma and chronic obstructive pulmonary disease, prompting a rapid technological transformation across the country’s healthcare sector. Against this backdrop, India’s diagnostic imaging market is projected to expand at a compound annual growth rate (CAGR) of 7% through 2035, forecasts GlobalData, a leading data and analytics company.
According to GlobalData’s Medical Intelligence Center, India accounts for 20% of the Asia-Pacific (APAC) diagnostic imaging market in 2025. This share is set to increase further as healthcare providers upgrade the existing infrastructure and adopt more sophisticated imaging technologies to support the early diagnosis, precise treatment planning, and continuous monitoring of chronic respiratory conditions.
Priyanka Chakraborty, Medical Devices Analyst at GlobalData, comments: “India bears a high burden of respiratory diseases, driven by air pollution, smoking, and occupational exposures. Limited access to affordable healthcare leads to many cases being misdiagnosed, mismanaged, or undiagnosed. Addressing this growing disease burden requires significant expansion of diagnostic and imaging capabilities, while ensuring these services remain cost-effective and accessible to the broader population.”
In November 2025, Cipla launched the Breathefree Lung Wellness Centre in New Delhi, India’s first integrated lung diagnostics and wellness facility. It offers 60+ tests including X-ray, CT scan another advanced lung function tests for people with or at risk of lung disease. The center also provides smoking cessation, pulmonary rehabilitation, and nutrition support, offering comprehensive, accessible, and affordable respiratory care.
The center combines Cipla’s longstanding respiratory expertise with advanced technology and protocols, delivered by trained technical professionals to ensure accurate testing, prompt detection, and precise diagnosis.
Chakraborty concludes: “As affordable diagnostic imaging facilities such as Cipla’s Breathefree Lung Wellness Centre expand in India, they are set to boost rapid detection, improve diagnostic accuracy, and enhance long-term outcomes for patients with respiratory diseases. With rapid growth in its diagnostic infrastructure, the country is strengthening its role as a regional hub for affordable, technology-driven imaging solutions.”
Notes:
Quotes provided by by Priyanka Chakraborty, Medical Devices Analyst at GlobalData
This press release was written using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis conducted by GlobalData’s team of industry experts
About GlobalData
4,000 of the world’s largest companies, including over 70% of FTSE 100 and 60% of Fortune 100 companies, make more timely and better business decisions thanks to GlobalData’s unique data, expert analysis and innovative solutions, all in one platform. GlobalData’s mission is to help our clients decode the future to be more successful and innovative across a range of industries, including the healthcare, consumer, retail, financial, technology and professional services sectors.